Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6

NCT02480166 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

PT-NANBH

Interventions

DRUG: 8 weeks SOF/LED
DRUG: 12 weeks SOF/LED

Sponsor

Stanford University

Collaborators

[object Object]